T cell response in hepatitis C virus infection
- PMID: 15653409
- DOI: 10.1016/j.jcv.2004.05.008
T cell response in hepatitis C virus infection
Abstract
Hepatitis C virus (HCV) is a hepatotropic RNA virus that causes acute and chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. It is widely accepted that cellular immune responses play an important role in viral clearance and disease pathogenesis. However, HCV often evades effective immune recognition and has a propensity to persist in the majority of acutely infected individuals (ca. 80%). The immunological and virological basis for the inefficiency of the cellular immune response to clear or control the virus is not known. Recent studies, however, have provided new insights into the mechanisms of viral clearance and persistence that will be discussed in detail.
Similar articles
-
Adaptive immune responses in acute and chronic hepatitis C virus infection.Nature. 2005 Aug 18;436(7053):946-52. doi: 10.1038/nature04079. Nature. 2005. PMID: 16107834 Review.
-
[The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].Z Gastroenterol. 2004 Jan;42(1):39-46. doi: 10.1055/s-2004-812688. Z Gastroenterol. 2004. PMID: 14997402 Review. German.
-
Success and failure of virus-specific T cell responses in hepatitis C virus infection.Dig Dis. 2011;29(4):416-22. doi: 10.1159/000329807. Epub 2011 Aug 30. Dig Dis. 2011. PMID: 21894013 Review.
-
[Immunology of hepatitis C: clinical significance of T cell response].Korean J Hepatol. 2006 Jun;12(2):140-53. Korean J Hepatol. 2006. PMID: 16804339 Review. Korean.
-
Interaction between the hepatitis C virus and the immune system.Semin Liver Dis. 2000;20(2):127-41. doi: 10.1055/s-2000-9946. Semin Liver Dis. 2000. PMID: 10946419 Review.
Cited by
-
Disease causality extraction based on lexical semantics and document-clause frequency from biomedical literature.BMC Med Inform Decis Mak. 2017 May 18;17(Suppl 1):53. doi: 10.1186/s12911-017-0448-y. BMC Med Inform Decis Mak. 2017. PMID: 28539124 Free PMC article.
-
Lipidoid Nanoparticles Containing PD-L1 siRNA Delivered In Vivo Enter Kupffer Cells and Enhance NK and CD8(+) T Cell-mediated Hepatic Antiviral Immunity.Mol Ther Nucleic Acids. 2013 Feb 19;2(2):e72. doi: 10.1038/mtna.2012.63. Mol Ther Nucleic Acids. 2013. PMID: 23423360 Free PMC article.
-
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate.Nat Commun. 2022 Nov 25;13(1):7271. doi: 10.1038/s41467-022-34961-8. Nat Commun. 2022. PMID: 36434005 Free PMC article.
-
HCV genome-wide genetic analyses in context of disease progression and hepatocellular carcinoma.PLoS One. 2014 Jul 31;9(7):e103748. doi: 10.1371/journal.pone.0103748. eCollection 2014. PLoS One. 2014. PMID: 25079603 Free PMC article.
-
Differential dysfunction in dendritic cell subsets during chronic HCV infection.Clin Immunol. 2007 Apr;123(1):40-9. doi: 10.1016/j.clim.2006.12.001. Epub 2007 Jan 17. Clin Immunol. 2007. PMID: 17239662 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical